For this reason, discussions around expectations, duration of therapy, and sustainability are essential before starting treatment
Ravi Rao April 8, 2026 GLP-1 receptor agonists, widely used for type 2 diabetes and weight management, often cause gastrointestinal side effects that clinicians must address proactively
Retatrutide is an investigational compound and is legal for research purposes in the US
Blood pressure changes are another consideration
Discuss supplements to take alongside your medication
Understanding GLP-1 drug names alongside your genetic profile empowers you to have deeper, more informed discussions with your provider about why a specific agentwhether branded semaglutide, compounded tirzepatide, or another optionmight align with your metabolic and clinical characteristics